Close
You must relate an iCM form to this article

Skip Navigation
Search site
Search Help

National Oesophago-Gastric Cancer Audit

The National Oesophago-Gastric Cancer Audit covers the quality of care given to patients with Oesophago-Gastric (OG) cancer. The audit evaluates the process of care and the outcomes of treatment for all OG cancer patients, both curative and palliative. From April 2012, the audit has been extended to include patients with Oesophageal High-Grade Glandular Dysplasia (HGD).

What does it measure?

  • characteristics of patients, their cancers and treatment selection
  • patterns of care received by curative and palliative patients
  • short term outcomes of both curative and palliative treatments
  • survival rates of patients
  • differences in survival rates by patient characteristics, cancer type and the treatments received
  • patients with oesophageal High-Grade Glandular Dysplasia (HGD).

Benefits

Survival depends on early diagnosis. The management of patients with this type of cancer is complex. The audit hopes to improve the process of care and the outcomes of treatment for all cancer patients, both curative and palliative by:

  • producing up-to-date information on the quality of care for OG cancer patients
  • providing downloadable data for OG cancer units on their practice and outcomes
  • satisfying General Medical Council (GMC) requirements for performance assessment and revalidation
  • directly supporting the "cancer measures" element of the peer review process.

Who manages the audit?

The audit is managed as a partnership between a team of clinicians and audit experts from:

  • The Association of Upper Gastrointestinal Surgeons of Great Britain & Ireland (AUGIS)
  • British Society of Gastroenterologists (BSG)
  • The Clinical Effectiveness Unit at the Royal College of Surgeons of England
  • Health and Social Care Information Centre 

The National Oesophago-Gastric Cancer Audit has been commissioned by the Healthcare Quality Improvement Partnership (HQIP).

What is included in the audit?

  1. a prospective study examining the care pathway and outcome for individual patients
  2. an organisational survey of all OG cancer units in England and Wales
  3. detailed analysis of existing data sources to describe recent patterns of OG cancer treatment.

How to participate

The audit has now been extended to include patients diagnosed with high-grade dysplasia of the Barrett's oesophagus (HGD) and a new data set has been designed which includes these new data items.  This new data set comes into effect for those patients diagnosed from 1 April 2012.  The data collection system has also been revised and will be used for collecting data on patients diagnosed from 1 April 2012. . 

The data submission deadline for this period of data collection is 1 October 2013. 

This data will be included in the third annual report due to be published in May 2014.

Participating trusts can submit data via a secure website to a protected central database.

Trusts can enter data into the audit IT system in two ways:

  1. directly into the database
  2. uploaded electronically (via CSV files) from existing information systems.

Access the Data Collection System

In order to access the new system, all users are required to re-register and attain approval for registration from the Caldicott Guardian

  1. Go to https://clinicalaudit.ic.nhs.uk
  2. If you have not already registered for a Single Sign On (SSO) account you will need to do so
  3. Sign in to https://clinicalaudit.ic.nhs.uk using your SSO credentials 
  4. Access the user registration form from the Documents for Data Submission from April 2012 file at the link above
  5. Fill in all the user details electronically
  6. Email the completed document to your Caldicott Guardian for approval. When you receive your confirmation e mail from ourselves you can logon to the system

Caldicott Guardian Approval

When the Caldicot guardian receives the e mailed registration form from the user they should electronically complete the Caldicott guardian section, save the document and then send the completed saved document by e mail to enquiries@hscic.gov.uk

Publication of the audit results

The national results of the new audit will be published in three annual reports, scheduled for July 2012, June 2013 and May 2014.

  • July 2012 annual report describes the results of the organisational audit, and the longer term outcomes of patients diagnosed in the first audit data collection period.
  • June 2013 annual report will describe, using the linked data set, the process and outcomes of care for patients diagnosed in the first year of the continuing audit. (1 April 2011 - 31 March 2012).

The submission deadline for this reporting period was 1 October 2012

  • May 2014 annual report will describe, using the linked data set, the process and outcomes of care for patients diagnosed in the first and second years of the continuing audit. (1 April 2011 - 31 March 2013) including patients diagnosed with oesophageal high-grade glandular dysplasia (HGD).

The submission deadline for this reporting period is 1 October 2013